Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
Clinical trial NCT06073821 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06073821
- Sponsor
- BeOne Medicines
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-11
- Primary completion
- 2032-02-01
- Enrollment
- 652
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.